Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
KEYSOURCE +
Third Extension - Granted
Show more
Class 5: Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose, throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements
Class 35: Distributorship services in the field of pharmaceutical products
Class 5 – Pharmaceuticals & supplementsClass 35 – Advertising & retail
Status timeline
- 29 Feb 2024Application filedNew Application Entered
- 17 Sep 2024Assigned to an examining attorneyAssigned To Examiner
- 1 Oct 2024Approved for publicationApproved For Pub - Principal Register
- 12 Nov 2024Published for oppositionPublished For Opposition
- 24 Dec 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 2 May 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 8 Dec 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 8 Apr 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 20 events
| 2026-04-09 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-04-08 | Sou Teas Extension Received |
| 2026-04-08 | Sou Extension 3 Filed |
| 2026-04-08 | Sou Extension 3 Granted |
| 2025-12-08 | Sou Teas Extension Received |
| 2025-12-08 | Sou Extension 2 Filed |
| 2025-12-08 | Sou Extension 2 Granted |
| 2025-12-08 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-05-02 | Sou Teas Extension Received |
| 2025-05-02 | Sou Extension 1 Filed |
| 2025-05-02 | Sou Extension 1 Granted |
| 2025-05-02 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-12-24 | Noa Mailed - Sou Required From Applicant |
| 2024-11-12 | Published For Opposition |
| 2024-11-12 | Official Gazette Publication Confirmation E-Mailed |
| 2024-10-23 | Notification Of Notice Of Publication E-Mailed |
| 2024-10-01 | Approved For Pub - Principal Register |
| 2024-09-17 | Assigned To Examiner |
| 2024-07-11 | New Application Office Supplied Data Entered |
| 2024-02-29 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose, throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements
Class 35 Advertising & retail
Distributorship services in the field of pharmaceutical products
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 10 Apr 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.